RU2010129033A - METHOD FOR INCREASING BACTERICIDAL ACTIVITY - Google Patents
METHOD FOR INCREASING BACTERICIDAL ACTIVITY Download PDFInfo
- Publication number
- RU2010129033A RU2010129033A RU2010129033/15A RU2010129033A RU2010129033A RU 2010129033 A RU2010129033 A RU 2010129033A RU 2010129033/15 A RU2010129033/15 A RU 2010129033/15A RU 2010129033 A RU2010129033 A RU 2010129033A RU 2010129033 A RU2010129033 A RU 2010129033A
- Authority
- RU
- Russia
- Prior art keywords
- nle
- peptides
- ala ser
- bactericidal activity
- tyr lys
- Prior art date
Links
Abstract
Способ повышения бактерицидной активности, заключающийся в обработке раны пептидами, используемыми в лекарственной основе, согласно изобретения, в качестве пептидов используют синтетические пептиды, имеющие структуру от LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO и до THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, м.м. от 1794 до 1397 дальтон, в качестве лекарственной основы используют физиологический раствор из расчета 10÷30 мг синтетических пептидов, 1 мл физиологического раствора. A method for increasing bactericidal activity, which consists in treating a wound with peptides used in a pharmaceutical basis, according to the invention, using peptides using synthetic peptides having a structure from LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO to THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, m. from 1794 to 1397 daltons, saline is used as a medicinal base at the rate of 10–30 mg of synthetic peptides, 1 ml of physiological saline.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129033/15A RU2448725C2 (en) | 2010-07-13 | 2010-07-13 | Method of increasing bactericidal activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010129033/15A RU2448725C2 (en) | 2010-07-13 | 2010-07-13 | Method of increasing bactericidal activity |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010129033A true RU2010129033A (en) | 2012-01-20 |
RU2448725C2 RU2448725C2 (en) | 2012-04-27 |
Family
ID=45785282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010129033/15A RU2448725C2 (en) | 2010-07-13 | 2010-07-13 | Method of increasing bactericidal activity |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2448725C2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1315229C (en) * | 1987-06-10 | 1993-03-30 | Patrick J. Baker | Chromatographic purification process |
RU2147238C1 (en) * | 1998-05-13 | 2000-04-10 | Институт клинической иммунологии СО РАМН | Method of treatment of patient with bacterial infection |
US6696412B1 (en) * | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
US7972814B2 (en) * | 2001-11-20 | 2011-07-05 | Novozymes Adenivro Biotech A/S | Antimicrobial polypeptides from Pseudoplectania nigrella |
-
2010
- 2010-07-13 RU RU2010129033/15A patent/RU2448725C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2448725C2 (en) | 2012-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012016853A2 (en) | "pharmaceutical compositions for oral administration of insulin peptides". | |
PE20142432A1 (en) | THERAPEUTIC USES OF PROTEINS FROM THE FIBROBLAST GROWTH FACTOR 21 | |
EA201290964A1 (en) | Peptide Conjugates of GLP-1 Receptor Agonists and Their Use | |
JP2014169326A5 (en) | ||
EA201491391A1 (en) | THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
EA201270824A1 (en) | COMPOUNDS TO REDUCE BET-AMYLOID PRODUCTS | |
WO2008075371A3 (en) | T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation | |
NZ592509A (en) | HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same | |
GT200900304A (en) | "CXCR4 CYCLE PEPTIDE ANTAGONISTS" | |
CY1117872T1 (en) | Oligopeptide compounds and their uses | |
CY1117582T1 (en) | USE OF A-CONFERENCE DIMENSIONS FOR LEWY BODY DISEASE TREATMENT | |
MA40709A1 (en) | Glucagon derivative with improved stability | |
EA201490790A1 (en) | Peptide Conjugates of Gastrin and Glyukagon Receptor Agonists | |
EA201101706A1 (en) | Drug medication based on diyndolylmethanum (DIM) with enhanced bioavailability and its use in the treatment of hyperplastic and inflammatory diseases | |
EA201491155A1 (en) | NEW MUTANT PRO-NRF AND THEIR APPLICATION TO GET BETA-NRF | |
EA201492010A1 (en) | APPLICATION OF HIGH DOSE OF LACHINIMODE FOR TREATMENT OF MULTIPLE SCLEROSIS | |
NZ600544A (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
EA201490901A1 (en) | LINKERS BASED ON TYROSINE FOR FREE CONNECTION OF PEPTIDE | |
EA201500061A1 (en) | PHARMACEUTICAL COMPOSITION FOR THERAPY FOR PULMONARY FORMS OF HIGH-DISTANCE DISEASE, CAUSED BY OXYGEN FASTENGEN AND REDUCED ATMOSPHERIC PRESSURE | |
CY1116234T1 (en) | Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2 / 3 conformers | |
EA201590601A1 (en) | APPLICATION OF PEDF-DERIVED POLYPEPTIDES FOR THE TREATMENT OF OSTEOARTHRITIS | |
PE20151746A1 (en) | BICYCLE COMPOUNDS | |
RU2013108390A (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OF PERIOPERATIVE ARTERIAL HYPOTENSION IN HUMAN | |
EP4218786A3 (en) | Opiorphin for use as analgesic agent | |
HRP20171993T1 (en) | Variants of human gdnf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20120714 |